Shares of UCB SA (OTCMKTS:UCBJY - Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $89.80 and traded as low as $84.33. UCB shares last traded at $85.80, with a volume of 123,782 shares changing hands.
UCB Stock Performance
The company has a 50-day moving average of $89.55 and a 200-day moving average of $94.13. The company has a current ratio of 1.19, a quick ratio of 0.78 and a debt-to-equity ratio of 0.33.
UCB Increases Dividend
The company also recently disclosed a dividend, which will be paid on Wednesday, May 14th. Shareholders of record on Tuesday, April 29th will be issued a dividend of $0.4838 per share. This represents a yield of 0.62%. This is an increase from UCB's previous dividend of $0.46. The ex-dividend date is Monday, April 28th.
About UCB
(
Get Free Report)
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.
Further Reading
Before you consider UCB, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UCB wasn't on the list.
While UCB currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
